Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-23-028607

Director bought 200,000 shares at $2.25 ($450,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SCHIMMEL PAUL Director 2023-05-10 Purchase +200,000 $2.25 $450,000 313,023 I
Open-market purchases · 200,000 sh · avg $2.25 · $450,000
Loading xslF345X04/doc4.xml…